First RCT showing leech therapy superior to topical diclofenac for OA pain
Clinical Evidence — Not FDA-Evaluated
Investigational use. Leech therapy for osteoarthritis is not FDA-cleared. This review summarizes the clinical trial evidence for educational purposes.
Before 2003, evidence for leech therapy in osteoarthritis was limited to case reports and traditional practice accounts spanning centuries. Michalsen et al. conducted the first rigorous randomized controlled trial, published in the Annals of Internal Medicine — one of the highest-impact general medical journals. This established leech therapy as a subject worthy of serious clinical investigation.[R1]
Single application of 4–6 Hirudo medicinalis to the affected knee. Leeches were applied around the joint line and allowed to feed until spontaneous detachment (typically 30–60 minutes).
Topical diclofenac gel (standard NSAID comparator) applied daily for 28 days. This was an active comparator design, making the results more clinically meaningful than placebo-controlled studies.
N = 51
Randomized patients
Knee OA
Symptomatic, confirmed
3–6 mo
Follow-up period
Data from Michalsen et al. (2003).[R1]
The leech therapy group demonstrated statistically significant and clinically meaningful improvements across all primary outcome measures:
| Measure | Baseline | Day 28 | Change |
|---|---|---|---|
| WOMAC total | 52.3 ± 14 | 27.1 ± 18 | −48% |
| WOMAC pain | 11.2 ± 3.5 | 5.0 ± 4.0 | −55% |
| VAS pain (0–100) | 53.5 | 19.3 | −35 mm |
| Physical function | 31.6 ± 10 | 17.2 ± 13 | −46% |
All comparisons p < 0.001 vs baseline. Leech group superior to diclofenac at all time points.[R1]
One of the most remarkable findings was the duration of therapeutic effect from a single application. Pain relief was evident within 3 days, peaked at 28 days, and remained clinically significant at 3–6 month follow-up. This prolonged effect from one treatment session suggests mechanisms beyond simple anticoagulation — likely involving sustained anti-inflammatory activity, local tissue remodeling, and possible modulation of pain signaling pathways.[R1]
Adverse events in the leech group were limited to expected local effects: mild bleeding at application sites (self-limiting within 24 hours), local pruritus (itching) lasting 2–3 days, and small ecchymoses. No serious adverse events, no infections, and no systemic complications were reported. The safety profile compared favorably to the diclofenac group, which reported gastrointestinal discomfort in several patients.[R1]
The Michalsen 2003 study catalyzed a series of subsequent RCTs that broadly confirmed the initial findings:
| Study | N | Design | Result |
|---|---|---|---|
| Andereya et al. 2006 | 113 | Sham-controlled (knee OA) | Significant pain reduction vs sham |
| Lauche et al. 2014 | 4 RCTs | Meta-analysis | Pooled therapeutic benefit confirmed |
The prolonged effect of a single leech application suggests multiple overlapping mechanisms:
Leech saliva contains multiple anti-inflammatory compounds (bdellins, eglins, hyaluronidase) that may reduce joint inflammation and synovial fluid viscosity.
Local blood flow improvement through anticoagulant and vasodilatory effects may reduce tissue hypoxia and promote healing in the peri-articular tissues.
Direct analgesic compounds in leech SGS (including antistasins and possible opioid-like peptides) may modulate pain signaling at the peripheral level.
The bite itself may activate descending pain inhibition pathways (diffuse noxious inhibitory control), similar to acupuncture mechanisms.
Effectiveness of Leech Therapy in Osteoarthritis of the Knee: A Randomized, Controlled Trial
Primary source. First randomized controlled trial of leech therapy for OA.
Effectiveness of Leech Therapy in Chronic Lateral Epicondylitis: A Randomized Controlled Trial
Subsequent Michalsen RCT extending leech therapy to musculoskeletal conditions.
Leeches for Osteoarthritis of the Knee: A Systematic Review and Meta-Analysis
Lauche et al. meta-analysis of 4 RCTs confirming positive pooled effect.
Added to ASH library: February 27, 2026 | Site last updated: March 14, 2026
This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.